Covered recipient · General Payments record
KARLA KAE HESS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,265.94
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.57 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $224.26 | 11 |
| GlaxoSmithKline, LLC. | $68.46 | 4 |
| Amgen Inc. | $64.47 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.24 | 2 |
| Astellas Pharma US Inc | $34.97 | 1 |
| Lilly USA, LLC | $31.85 | 2 |
| PFIZER INC. | $17.91 | 1 |
| Novo Nordisk AS | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.41 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328220 | CMS |
| ABBVIE INC. | $16.94 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328222 | CMS |
| ABBVIE INC. | $24.46 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328224 | CMS |
| ABBVIE INC. | $26.27 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328226 | CMS |
| ABBVIE INC. | $14.57 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328228 | CMS |
| ABBVIE INC. | $17.55 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328230 | CMS |
| ABBVIE INC. | $29.77 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328232 | CMS |
| ABBVIE INC. | $17.47 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328234 | CMS |
| ABBVIE INC. | $14.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328236 | CMS |
| ABBVIE INC. | $19.39 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328238 | CMS |
| ABBVIE INC. | $28.11 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107328240 | CMS |
| Amgen Inc. | $25.68 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276782 | CMS |
| Amgen Inc. | $25.54 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276784 | CMS |
| Amgen Inc. | $13.25 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117276780 | CMS |
| Astellas Pharma US Inc | $34.97 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139512039 | CMS |
| GlaxoSmithKline, LLC. | $15.29 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115886347 | CMS |
| GlaxoSmithKline, LLC. | $20.52 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116242079 | CMS |
| GlaxoSmithKline, LLC. | $13.31 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116597785 | CMS |
| GlaxoSmithKline, LLC. | $19.34 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116388696 | CMS |
| Lilly USA, LLC | $18.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135725633 | CMS |
| Lilly USA, LLC | $13.25 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135723157 | CMS |
| Novartis Pharmaceuticals Corporation | $18.39 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086819877 | CMS |
| Novartis Pharmaceuticals Corporation | $21.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086819901 | CMS |
| Novo Nordisk Inc | $13.41 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100465802 | CMS |
| PFIZER INC. | $17.91 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130946028 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.